Low-dose antithymocyte globulin enhanced the efficacy of tacrolimus and mycophenolate for GVHD prophylaxis in recipients of unrelated SCT. - Wikidata - awgldk - TriplyDB

Low-dose antithymocyte globulin enhanced the efficacy of tacrolimus and mycophenolate for GVHD prophylaxis in recipients of unrelated SCT.

Low-dose antithymocyte globulin enhanced the efficacy of tacrolimus and mycophenolate for GVHD prophylaxis in recipients of unrelated SCT.

http://www.wikidata.org/entity/Q34860077

about

Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.Blood concentration of cyclosporine during early post-transplant period may have influence on the occurrence of chronic graft versus host disease in patients who received allogeneic hematopoietic stem cell transplantation In-vivo or ex-vivo T cell depletion or both to prevent graft-versus-host disease after hematopoietic stem cell transplantation.

P2860

Q37618811-0DD12AC0-8925-4824-AB00-C76DAA8B28D4 Q37644959-03CA58B6-C9F4-4ED1-8EEF-FA64150A5E81 Q48680865-2EDB2D58-1C02-40C1-980C-18D100B53E29

P2860

Low-dose antithymocyte globulin enhanced the efficacy of tacrolimus and mycophenolate for GVHD prophylaxis in recipients of unrelated SCT.

http://www.wikidata.org/entity/Q34860077

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Low-dose antithymocyte globuli ...... n recipients of unrelated SCT.

@ast

Low-dose antithymocyte globuli ...... n recipients of unrelated SCT.

@en

Low-dose antithymocyte globuli ...... n recipients of unrelated SCT.

@nl

type

label

Low-dose antithymocyte globuli ...... n recipients of unrelated SCT.

@ast

Low-dose antithymocyte globuli ...... n recipients of unrelated SCT.

@en

Low-dose antithymocyte globuli ...... n recipients of unrelated SCT.

@nl

prefLabel

Low-dose antithymocyte globuli ...... n recipients of unrelated SCT.

@ast

Low-dose antithymocyte globuli ...... n recipients of unrelated SCT.

@en

Low-dose antithymocyte globuli ...... n recipients of unrelated SCT.

@nl

P1433

Q34860077-B2C22701-2E3B-4B90-9C58-32A430112636

P1476

Q34860077-030A95DD-74C0-4791-B333-283D2124DF4C

P2093

Q34860077-48A75CFD-C320-42BE-B19C-387E2EF51D8F

Q34860077-65ED0F59-E339-4EAE-9C4E-A63335E71A83

Q34860077-6B07A834-A07D-43AB-B550-4E0DFCFB2598

Q34860077-73C23E1E-89DF-44C3-B769-93C225A14B86

Q34860077-7F140871-116B-41D3-AAFF-5473D88DADCC

Q34860077-974AB9DA-B178-4996-BBD8-0C7C2AB00C0C

Q34860077-A28CB54C-036E-425B-B03F-0379912431F2

Q34860077-B4B328BE-8B3C-4AB9-B512-C7DF208F7DE8

Q34860077-C37517B7-32E4-4332-B2E0-05795500C4B0

Q34860077-D7B79E07-EE16-4956-AC6F-B77057D43C0A

P2860

Q34860077-0148F8A4-1571-4219-A4F6-3AE4784E1F9C

Q34860077-0452F8E1-BE52-4B57-9D1B-29D224831B45

Q34860077-0734C745-1ADB-460C-9ADD-14552D0B4407

Q34860077-1B3ED9DE-FE2B-4E9E-A6FF-C7318504BA19

Q34860077-23EFEDF1-6459-44D3-A130-4B17DA9CACDA

Q34860077-267D9B93-E353-47B6-8CD3-1E6B097EEAD8

Q34860077-31D0A8DB-3274-44A0-B9CC-26722779F5E8

Q34860077-32B90927-C3DD-488A-9DB8-5379EAC68730

Q34860077-33B868D4-B11C-4B1A-8759-B826A1F5F802

Q34860077-3ABC9796-AF4D-4119-A7A8-6B7515D6AF20

P2888

Q34860077-B2153412-C0EB-4626-882E-5223B28F4105

P304

Q34860077-EB36FFD7-672D-4A69-A43D-00E45E1384B2

P31

Q34860077-A5236359-A965-4A2F-8C46-F406FE16A666

P356

Q34860077-2C1B43B6-E844-4C68-B64D-91F791B2CDE8

P407

Q34860077-2831F04B-C13B-411E-8BAC-F2C85BF5486B

P433

Q34860077-31CE783D-0B5B-4583-A456-245184B7563E

P478

Q34860077-DC0AA856-4F27-42E5-B2D7-784A4E755B3B

P577

Q34860077-1B004041-DB39-470A-9963-0115D7ED2EBC

P5875

Q34860077-FF96BD52-C687-4B5A-8405-385A1A31A12C

P6179

Q34860077-D5FEF775-2D9F-48D0-9287-6155E6F4C235

P698

Q34860077-5484AA38-AB28-45C7-9CCC-D779B27F5D96

P932

Q34860077-8071142F-2CE3-48E5-BB7F-5C4B3D507284

P356

P1433

Bone Marrow Transplantation

P1476

Low-dose antithymocyte globuli ...... n recipients of unrelated SCT.

@en

P2093

A Deol

http://www.w3.org/2001/XMLSchema#string

D Bhutani

http://www.w3.org/2001/XMLSchema#string

J P Uberti

http://www.w3.org/2001/XMLSchema#string

K Mellert

http://www.w3.org/2001/XMLSchema#string

L Ayash

http://www.w3.org/2001/XMLSchema#string

L G Lum

http://www.w3.org/2001/XMLSchema#string

M Abidi

http://www.w3.org/2001/XMLSchema#string

M Ventimiglia

http://www.w3.org/2001/XMLSchema#string

S Cronin

http://www.w3.org/2001/XMLSchema#string

V Ratanatharathorn

http://www.w3.org/2001/XMLSchema#string

P2860

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

Nonparametric Estimation from Incomplete Observations

Clinical applications of rituximab in allogeneic stem cell transplantation: anti-tumor and immunomodulatory effects.

Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation.

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Improved outcomes using tacrolimus/sirolimus for graft-versus-host disease prophylaxis with a reduced-intensity conditioning regimen for allogeneic hematopoietic cell transplant as treatment of myelofibrosis

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.

Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond.

P2888

P304

106-112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2014.203

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266624946

http://www.w3.org/2001/XMLSchema#string

P6179

1022514371

http://www.w3.org/2001/XMLSchema#string

P698

25285804

http://www.w3.org/2001/XMLSchema#string

P932

4286438

http://www.w3.org/2001/XMLSchema#string